# From Lab to Industry: Advancing the Translational Potential of Extracellular Vesicles Through the ISEV Translation, Regulation and Advocacy Committee (ISEV‐TRA)

## TL;DR

This paper discusses how extracellular vesicles (EVs) can be better translated into real-world applications through a new committee that promotes collaboration and regulatory clarity.

## Contribution

The paper introduces the ISEV-TRA committee to address translational barriers of EVs through cross-sector collaboration and regulatory advocacy.

## Key findings

- EVs have broad applications but face challenges in translation due to scientific, regulatory, and manufacturing issues.
- ISEV-TRA aims to bridge the gap between research and commercialization by fostering collaboration and developing resources.
- The committee promotes dialogue among stakeholders to shape the global roadmap for EV translation.

## Abstract

Extracellular vesicles (EVs) have emerged as powerful mediators of intercellular communication with significant potential across biomedical, veterinary, cosmetic, agricultural and environmental applications. However, the translation of EV‐based discoveries into practical and commercially viable products remains constrained by scientific complexity, regulatory uncertainty and manufacturing challenges. To address these barriers, the International Society for Extracellular Vesicles (ISEV) established the Translation, Regulation and Advocacy Committee (ISEV‐TRA). ISEV‐TRA aims to catalyse the responsible advancement of EV technologies by fostering cross‐sector collaboration, harmonising quality and regulatory frameworks and providing strategic advocacy to enhance market readiness. Through targeted initiatives—such as workshops and the development of translational resources and guidance—ISEV‐TRA seeks to bridge the gap between research and real‐world implementation. By promoting dialogue amongst academia, industry, investors and policymakers, ISEV‐TRA positions itself as a central driver in shaping the global roadmap for EV translation and commercialisation.